A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/2001
11/15/2001	WO2001085956A2 Lipid metabolism enzymes
11/15/2001	WO2001085955A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	WO2001085953A1 Sphingosine kinase and uses thereof
11/15/2001	WO2001085944A2 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
11/15/2001	WO2001085942A2 Cytoskeleton-associated proteins
11/15/2001	WO2001085941A2 Myc targets
11/15/2001	WO2001085940A2 USE OF hTAFII80 AND ISOFORMS THEREOF FOR INDUCING APOPTOSIS
11/15/2001	WO2001085917A2 A device
11/15/2001	WO2001085798A2 Human monoclonal antibodies to dendritic cells
11/15/2001	WO2001085790A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
11/15/2001	WO2001085789A2 Extracellular domain of ryk protein for regulating angiogenesis
11/15/2001	WO2001085785A2 Ph domain-interacting protein
11/15/2001	WO2001085784A2 POLYNUCLEOTIDES ENCODING FOR POLYMORPHIC ISOFORMS OF THE PTHrP PROTEIN, THE ENCODED PROTEINS AND THEIR THERAPEUTIC APPLICATIONS THEREOF
11/15/2001	WO2001085779A2 Protein complexes and assays for screening anti-cancer agents
11/15/2001	WO2001085778A1 A new polypeptide -human tubulin folding cofactor c13 and the polynucleotide encoding it
11/15/2001	WO2001085775A1 A novel human hepatoma associated protein and the polynucleotide encoding said polypeptide
11/15/2001	WO2001085763A2 Chimeric peptide immunogens their preparation and use
11/15/2001	WO2001085762A2 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	WO2001085755A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	WO2001085751A1 Polymeric compounds useful as prodrugs
11/15/2001	WO2001085736A1 Porphyrin-based neutron capture agents for cancer therapy
11/15/2001	WO2001085733A1 Interstrand crosslinking agents for dna and compounds therefor
11/15/2001	WO2001085729A1 Novel vitronectin receptor antagonists
11/15/2001	WO2001085726A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001	WO2001085719A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	WO2001085718A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	WO2001085716A1 2-piperidone compounds for the treatment of cancer
11/15/2001	WO2001085715A2 Aza- and polyazanthranyl amides and their use as medicaments
11/15/2001	WO2001085709A2 New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
11/15/2001	WO2001085697A1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
11/15/2001	WO2001085686A2 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
11/15/2001	WO2001085685A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
11/15/2001	WO2001085677A1 Amino acid derivatives and their use as medicines
11/15/2001	WO2001085671A2 Anthranyl amides and their use as medicaments
11/15/2001	WO2001085219A2 Identification, diagnosis, and treatment of breast cancer
11/15/2001	WO2001085213A2 Supports for photosensitizer formulations
11/15/2001	WO2001085212A2 Drug delivery systems for photodynamic therapy
11/15/2001	WO2001085210A2 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001	WO2001085209A2 Treating t-cell mediated diseases by modulating dr6 activity
11/15/2001	WO2001085208A2 Molecular antigen arrays and vaccines
11/15/2001	WO2001085204A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085203A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	WO2001085196A2 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001	WO2001085195A1 Small peptide amides inhibiting the proliferation of cancer cells
11/15/2001	WO2001085194A1 Method and composition for the treatment of angiogenesis
11/15/2001	WO2001085192A1 Transgenically produced decorin
11/15/2001	WO2001085178A1 Nutritional preparation comprising ribose and folic acid and medical use thereof
11/15/2001	WO2001085166A1 Methods for inhibiting proliferation and inducing apoptosis in cancer cells
11/15/2001	WO2001085147A2 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL) ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL) BENZO[b]THIOPHENE AND SALTS THEREOF
11/15/2001	WO2001085144A2 Use of substituted acryloyl distamycin derivatives in the treatment of tumors associated with high levels of glutathione
11/15/2001	WO2001085142A1 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
11/15/2001	WO2001085141A1 β-GLUCANS ENCAPSULATED IN LIPOSOMES
11/15/2001	WO2001084929A1 Antitubulin assembly and cell growth inhibitor denominated 'dioxostatin'
11/15/2001	WO2001055172A3 ISOLATED COMPLEX COMPRISING A NNT-1 PROTEIN AND IN ADDITION AT LEAST A CLF-1 PROTEIN AND/OR A sCNTFRα PROTEIN
11/15/2001	WO2001042794A3 Method for identifying inhibitors of cytokinesis
11/15/2001	WO2001016136B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
11/15/2001	WO2001007088A3 Methods for treating therapy-resistant tumors
11/15/2001	WO2001006756A3 Use of diphenyliodonium for the activation and protection of cytotoxic lymphocytes
11/15/2001	WO2001003717A3 Methods of inducing cell death
11/15/2001	WO2001002594A3 DNA CONSTRUCTS BASED ON THE eIF4A GENE PROMOTER
11/15/2001	WO2001002550A3 Cell death related drug targets in yeast and fungi
11/15/2001	WO2000064484A3 Conjugate having a cleavable linkage for use in a liposome
11/15/2001	WO2000057865A9 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
11/15/2001	WO2000053232A9 Matriptase, a serine protease and its applications
11/15/2001	WO2000047729A9 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
11/15/2001	WO2000026370A9 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/15/2001	US20010041726 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041718 Cis-6-(4-fluoro-phenyl)-5-(4-(2-piperidin-1-yl-ethoxy)-phenyl) -5,6,7,8-tetrahydronaphthalene-2-ol, for example, and other estrogen agonists/antagonists to treat rheumatoid arthritis, colon cancer, wounds, cataracts and skin wrinkles
11/15/2001	US20010041713 Cyclooxygenase-2 (COX-2); administering 2-(2-methylpyrid-5-yl),3-(p-methylsulfonylphenyl),5-chloro-pyridine, or salt, hydrate or N-oxide thereof, alone or in combination with other drugs
11/15/2001	US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001	US20010041705 Heterocyclic carboxamides
11/15/2001	US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts
11/15/2001	US20010041681 Therapeutically useful synthetic oligonucleotides
11/15/2001	US20010041191 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate
11/15/2001	US20010041189 Dipeptide containing glutamic acid
11/15/2001	US20010041163 Xanthene dye structure with a hydrophilic and lipophilic group bound to the same carbon, ultrasonic
11/15/2001	DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001	CA2803844A1 Compositions and methods for demonstrating secretory immune system regulation of steroid hormone responsive cancer cell growth
11/15/2001	CA2776904A1 A device for forming or increasing the number of undifferentiated cells
11/15/2001	CA2691739A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo [b]thiophene and salts thereof
11/15/2001	CA2409759A1 Method and composition for the treatment of angiogenesis
11/15/2001	CA2409758A1 Novel multicyclic compounds and the use thereof
11/15/2001	CA2409679A1 Bacterial carboxypeptidase cpg2 variants and their use in gene directed enzyme prodrug therapy
11/15/2001	CA2409150A1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
11/15/2001	CA2408840A1 Myc targets
11/15/2001	CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	CA2408632A1 Ph domain-interacting protein
11/15/2001	CA2408622A1 Methods for inhibiting proliferation and inducing apoptosis in cancer cells
11/15/2001	CA2408594A1 Human monoclonal antibodies to dendritic cells
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408563A1 Stabilized formulations of 6-hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof
11/15/2001	CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408448A1 Indazoles substituted with 1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
11/15/2001	CA2408349A1 Method of regulating angiogenesis unsing ryk protein
11/15/2001	CA2408319A1 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents

1 ... 1772 1773 1774 1775 1776 1777 1778 1779 1780 1781 1782 1783 1784 1785 1786 1787 1788 1789 1790 1791 1792 ... 2211